June 22nd, 2016|
The FDA is investigating claims that popular migraine treatment patch Zecuity® may cause serious side effects such as burns, scars, and damaged skin.
The Zecuity patch contains the active ingredient sumatriptan, a prescription medicine used to treat acute migraine headaches in adults. It is manufactured by Teva Pharmaceuticals. The patch delivery system is designed to deliver a dose of medicine by way of a single-use, battery-powered patch that is wrapped around the upper arm or thigh.
According to the FDA, since marketing of the Zecuity patch began in September 2015, a large number of patients have reported they experienced burns or scars on the skin where the patch was worn. Teva Pharmaceuticals suspended sales, marketing and distribution on June 10, 2016.
The reports included the following serious adverse events:
- Severe redness
- Skin discoloration
- Cracked skin
If you experienced skin damage as a result of using Zecuity® (sumatriptan) migraine patch, contact Cory Watson Attorneys. Our law firm has recovered more than $2.7 billion for injury victims nationwide, and we’re available to review your case for free 24 hours a day, 7 days a week.
Get Help With Your Zecuity® Migraine Patch Lawsuit
If you or someone you love developed skin damage as a result of using Zecuity® (sumatriptan) migraine patch, you may be entitled to comepansation. Don’t let drug companies get away with producing products that cause more harm than good — call (877) 562-0000 or complete our free initial consultation form to get experienced legal help now.
Do not stop taking any medication without consulting your doctor.
Zecuity® is a registered trademark of Teva Pharmaceuticals. This law firm is not associated with, sponsored by, or affiliated with Teva Pharmaceuticals.